Peripheral Arterial Disease Clinical Trial
Official title:
Impact of Multidisciplinary Critical Limb Ischemia Team on the Utilization of Vascular Studies, Patient Management, AMPutation and Long-term Outcomes: The CLI-AMP Registry
Single-center, observational registry study with a prospective and retrospective arm to evaluate the impact of multidisciplinary CLI teams and protocol on amputation rates, vascular studies, revascularization, in-hospital and long-term outcomes.
It is well known from large Medicare and National Inpatient Sample databases that vascular
evaluations in patients with critical limb ischemia (CLI) and at risk for amputations remains
extremely low. However, this data is largely pulled from the early 2000s with a scarcity in
studies from this recent decade. A recent study showed that Medicare patients from 2011
showed that 23% of patients received primary major amputation. In a recent retrospective
analysis preformed at this institution, all amputation patients from 2011-2017 were evaluated
for vascular work up and long-term mortality. This cohort included 698 patients with 1009
amputated specimens (major and minor). This means that this institution is preforming around
140 amputations per year, which can be considered unacceptably high. Only 50% received any
form of vascular study (ankle-brachial index, doppler ultrasound, and computed tomography
angiography) within the year prior to amputation. Furthermore, only 30% of patients received
an angiogram within the year prior to amputation. In addition, all major amputations received
histopathological analysis, which confirmed that 62% the specimens were graded with severe
atherosclerosis. Even in this present decade, with the knowledge that CLI patients are not
receiving proper evaluation and treatment leading to amputation which is associated with
extreme mortality rates and a large economic burden, health care facilities are not improving
their care.
Multidisciplinary teams are a recommendation from the American Heart Association/American
College of Cardiology guidelines for managing peripheral vascular disease. Multidisciplinary
team approaches in other cardiovascular diseases, such as structural heart disease, has long
been validated. Literature regarding the implementation of "CLI Teams" remains scarce and not
widely adopted. However, institutions that have implemented a CLI Team that engages with
specialists from multiple disciplines have shown successful decrease in amputation rates and
increases in vascular evaluations and revascularization in these patients. The goal for this
study is to establish a hospital-based, physician and nurse led, multidisciplinary team to
deliver comprehensive care to CLI patients. We believe it is important to document the
experience of building a CLI Team and care protocols to provide insight and validated data
for other programs to implement. The multidisciplinary team will include vascular
interventionalists, hospitalists, podiatry, wound care, infectious disease, nephrology,
orthopedics, pharmacists, emergency department physicians, mid-level providers, nursing
staff, and vascular technologists. The ultimate goal is amputation prevention and wound
healing through comprehensive vascular care and data driven patient outcomes.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT06032065 -
Sequential Multiple Assessment Randomized Trial of Exercise for PAD: SMART Exercise for PAD (SMART PAD)
|
Phase 3 | |
| Active, not recruiting |
NCT03987061 -
MOTIV Bioresorbable Scaffold in BTK Artery Disease
|
N/A | |
| Recruiting |
NCT03506633 -
Impacts of Mitochondrial-targeted Antioxidant on Peripheral Artery Disease Patients
|
N/A | |
| Active, not recruiting |
NCT03506646 -
Dietary Nitrate Supplementation and Thermoregulation
|
N/A | |
| Active, not recruiting |
NCT04677725 -
NEtwork to Control ATherothrombosis (NEAT Registry)
|
||
| Recruiting |
NCT05961943 -
RESPONSE-2-PAD to Reduce Sedentary Time in Peripheral Arterial Disease Patients
|
N/A | |
| Recruiting |
NCT06047002 -
Personalised Antiplatelet Therapy for Patients With Symptomatic Peripheral Arterial Disease
|
||
| Completed |
NCT03185052 -
Feasibility of Outpatient Care After Manual Compression in Patients Treated for Peripheral Arterial Disease by Endovascular Technique With 5F Sheath Femoral Approach
|
N/A | |
| Recruiting |
NCT05992896 -
A Study of Loco-Regional Liposomal Bupivacaine Injection
|
Phase 4 | |
| Completed |
NCT04635501 -
AbsorbaSeal (ABS 5.6.7) Vascular Closure Device Trial
|
N/A | |
| Recruiting |
NCT04584632 -
The Efemoral Vascular Scaffold System (EVSS) for the Treatment of Patients With Symptomatic Peripheral Vascular Disease From Stenosis or Occlusion of the Femoropopliteal Artery
|
N/A | |
| Withdrawn |
NCT03994185 -
The Merit WRAPSODY™ Endovascular Stent Graft for Treatment of Iliac Artery Occlusive Disease
|
N/A | |
| Withdrawn |
NCT03538392 -
Serranator® Alto Post Market Clinical Follow Up (PMCF) Study
|
||
| Recruiting |
NCT02915796 -
Autologous CD133(+) Cells as an Adjuvant to Below the Knee Percutaneous Transluminal Angioplasty
|
Phase 1 | |
| Active, not recruiting |
NCT02900924 -
Observational Study to Evaluate the BioMimics 3D Stent System: MIMICS-3D
|
||
| Completed |
NCT02901847 -
To Evaluate the Introduction of a Public Health Approach to Peripheral Arterial Disease (PAD) Using National Centre for Sport and Exercise Medicine Facilities.
|
N/A | |
| Not yet recruiting |
NCT02455726 -
Magnesium Oral Supplementation to Reduce Pain Inpatients With Severe Peripheral Arterial Occlusive Disease
|
N/A | |
| Withdrawn |
NCT02126540 -
Trial of Pantheris System, an Atherectomy Device That Provides Imaging While Removing Plaque in Lower Extremity Arteries
|
N/A | |
| Not yet recruiting |
NCT02387450 -
Reduced Cardiovascular Morbi-mortality by Sildenafil in Patients With Arterial Claudication
|
Phase 2/Phase 3 | |
| Completed |
NCT02384980 -
Saving Life and Limb: FES for the Elderly With PAD
|
Phase 1 |